Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

Boriani, UĞUR; Proietti, Marco; Laroche, Cecile; Fauchier, Laurent; Marin, Francisco; Nabauer, Michael; Potpara, Tatjana; Dan, Gheorghe-Andrei; Kalarus, Zbigniew; Tavazzi, Luigi; Maggioni, Aldo; Lip, Gregory

doi:10.1093/europace/euz032

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

Boriani G., Proietti M., Laroche C., Fauchier L., Marin F., Nabauer M., ...Daha Fazla

EUROPACE, cilt.21, sa.7, ss.1013-1022, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 7
Basım Tarihi: 2019
Doi Numarası: 10.1093/europace/euz032
Dergi Adı: EUROPACE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1013-1022
Anahtar Kelimeler: Atrial fibrillation, Stroke, Antithrombotic therapy, Observational registries, Outcomes, EORP-AF registry, ANTICOAGULATED PATIENTS, ORAL ANTICOAGULATION, STROKE PREVENTION, MANAGEMENT, INSIGHTS
Hacettepe Üniversitesi Adresli: Evet

Özet

Aims In recent years, stroke prevention in patients with atrial fibrillation (AF) has radically changed, with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs). Contemporary European data on AF thromboprophylaxis are needed.